Bharat Biotech’s ‘COVAXIN’ gets approval for phase 3 trials in India
Team Udayavani, Oct 23, 2020, 9:26 AM IST
Covaxin, the coronavirus vaccine being developed by Bharat Biotech and ICMR, has received the approval by the Drugs Controller General of India (DCGI) to conduct the third phase of clinical trials.
The expert panel’s approval came after assessing data from Phases 1 and 2 along with animal trials. However, the committee suggested “minor amendments” in the protocol.
The study would cover 28,500 participants aged 18 years and above across 10 states. The Serum Institute of India began phase 3 clinical trial of Oxford vaccine last month.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Shah Rukh Khan turns 59, fans wait outside Mannat to catch superstar’s glimpse
Farooq Abdullah seeks inquiry into spike in terror attacks in Valley since Omar’s swearing-in
Sabarimala pilgrims to get free insurance coverage of Rs five lakh
Delhi: Woman chops off her husband’s private parts
Man who threw stub near CRPF school among 50 questioned, not certain if he triggered blast: police
MUST WATCH
Latest Additions
Shah Rukh Khan turns 59, fans wait outside Mannat to catch superstar’s glimpse
Farooq Abdullah seeks inquiry into spike in terror attacks in Valley since Omar’s swearing-in
Sabarimala pilgrims to get free insurance coverage of Rs five lakh
Delhi: Woman chops off her husband’s private parts
Man who threw stub near CRPF school among 50 questioned, not certain if he triggered blast: police
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.